In the BioHarmony Drug Report Database
Phenoxybenzamine
Dibenzyline (phenoxybenzamine) is a small molecule pharmaceutical. Phenoxybenzamine was first approved as Dibenzyline on 1982-01-01. It is used to treat malignant hypertension, pheochromocytoma, urinary bladder neck obstruction, and urinary incontinence in the USA. The pharmaceutical is active against alpha-2B adrenergic receptor.
Trade Name
|
Dibenzyline |
|---|---|
Common Name
|
phenoxybenzamine |
ChEMBL ID
|
CHEMBL753 |
Indication
|
malignant hypertension, pheochromocytoma, urinary bladder neck obstruction, urinary incontinence |
Drug Class
|
Image (chem structure or protein)